Close

BMO Capital on Bristol-Myers Squibb Co. (BMY): 'likely down on sympathy at open but potentially overdone' Nov 20, 2023 08:46AM
Merck (MRK) strengthens growth narrative, Bristol-Myers Squibb (BMY) 'difficult to own' - BMO Capital Oct 27, 2023 10:54AM
BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform Oct 27, 2023 04:05AM
Mirati Therapeutics (MRTX) seen worth more than double in a buyout Nov 23, 2022 12:40PM
Bristol-Myers Squibb Co. (BMY) PT Raised to $94 at BMO Capital; 'Home Run for Deucra Labeling in Psoriasis' Sep 12, 2022 06:21AM
View Older Stories

May 2, 2022 06:55AM Bristol-Myers Squibb Co. (BMY) PT Raised to $92 at BMO Capital on Camzyos Approval
Apr 29, 2022 07:53AM BMO Capital Reiterates Outperform Rating on Bristol-Myers Squibb Co. (BMY)
Apr 18, 2022 09:23AM Pre-Open Stock Movers 04/18: Casa Systems and Natus Medical Higher; TG Therapeutics and Nektar Lower (more...)
Mar 30, 2022 09:21AM Bristol-Myers Squibb Co. (BMY) PT Raised to $81 at BMO Capital
Mar 14, 2022 08:42AM BMO Capital Reiterates Bristol-Myers Squibb (BMY) Outperform, Bempeg in Melanoma Was Incremental to BMY's Thesis
Feb 7, 2022 07:21AM Bristol-Myers Squibb Co. (BMY) PT Raised to $74 at BMO Capital
Feb 4, 2022 07:49AM 2022 Product Launches Will Provide Good Foundation for Bristol-Myers Squibb's (BMY) Future Growth, Reiterate Outperform - BMO Capital
Nov 18, 2021 04:06PM UPDATE: BMO Capital Starts Bristol-Myers Squibb Co. (BMY) at Outperform
Apr 26, 2019 07:46AM Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at BMO Capital
Apr 17, 2019 06:46AM Bristol-Myers Squibb Co. (BMY) PT Raised to $63 at BMO Capital
Mar 20, 2019 06:51AM Bristol-Myers Squibb (BMY) PT Raised At BMO On Combination With Celgene
Feb 19, 2019 08:50AM Bristol-Myers Squibb (BMY) PT Cut To $59 At BMO On Reduced Opdivo Opportunity
Jan 25, 2019 08:45AM BMO Capital Reiterates Outperform on Bristol-Myers Squibb (BMY)
Jan 3, 2019 11:32AM Bristol-Myers Squibb (BMY) Should Have Support Around $45 - BMO
Dec 6, 2018 03:59AM BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
Nov 27, 2018 07:47AM UPDATE: Bristol-Myers Squibb Co. (BMY) PT Lowered to $56 at BMO Capital
Oct 26, 2018 08:36AM Bristol-Myers Squibb Co. (BMY) PT Raised to $55 at BMO Capital
Oct 23, 2018 07:11AM Bristol-Myers Squibb Co. (BMY) PT Lowered to $54 at BMO Capital
Jul 27, 2018 08:21AM Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at BMO Capital
Jul 23, 2018 07:44AM (BMY) PT Raised to $51 at BMO Capital
Apr 27, 2018 04:10AM BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Market Perform Citing More Balanced Risk/Reward
Apr 17, 2018 12:22PM Bristol-Myers Squibb Co. (BMY) PT Lowered to $47 at BMO Capital; 'More Headwinds and Uncertainty Ahead'
Apr 9, 2018 09:48AM Merck's Keytruda helps lung cancer patients live longer in trial
Feb 6, 2018 06:51AM Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at BMO Capital; 'IO NSCLC Complexity Increases'
Jan 30, 2018 12:54PM Pfizer (PFE) Not Hungry for a Large Deal - BMO
Nov 13, 2017 06:51AM Pfizer (PFE) Should Buy Biogen (BIIB) Instead - BMO
Jul 31, 2017 09:32AM Pre-Open Stock Movers 07/31: (DVAX) (CHTR) (DAN) Higher; (HTZ) (CLVS) (ICPT) Lower (more...)
Jul 28, 2017 07:01AM Bristol-Myers Squibb (BMY): IO Uncertainty Drives PT Decrease - BMO
Jul 27, 2017 12:38PM Bristol-Myers Squibb's (BMY) Call Didn't Alleviate Concerns - BMO
Jul 13, 2017 08:52AM If AstraZeneca (AZN) Soriot Rumors are True, It Becomes a Pfizer (PFE) Acquisition Target Again; Negative for Bristol-Myers (BMY)
May 3, 2017 02:53AM BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Underperform
Apr 21, 2017 06:58AM Bristol-Myers Squibb (BMY): Takeout Unlikely - BMO
Apr 3, 2017 01:44PM BMO Capital Maintains Market Perform Rating and $45 PT on Bristol-Myers Squibb (BMY) Following Results from CM-067 Study; Expectations to Decline for Opdivo + Yervoy
Feb 21, 2017 09:06AM BMO Capital Opines on Possible Bristol-Myers (BMY) Acquisition
Jan 31, 2017 03:04PM Bristol-Myers Squibb (BMY) Takeover Less Likely Following Pfizer (PFE) Call - BMO
Jan 23, 2017 01:46PM Bristol-Myers Squibb Co. (BMY) PT Lowered to $47 at BMO Capital; See Much Uncertainty and Increased Risk
Jan 20, 2017 07:15AM Bristol-Myers Squibb Co. (BMY): Execution Risk Higher - BMO
Jan 17, 2017 10:29AM AstraZeneca (AZN) MYSTIC Change Positive for Merck (MRK), Less so for Bristol-Myers Squibb (BMY) - BMO
Nov 9, 2016 12:03PM Complete Donald Trump Stock Impact Guide
Nov 9, 2016 07:54AM Major Pharma Got a Major Win Last Night - BMO
Oct 24, 2016 03:30PM Notable 52-Week Highs and Lows 10/24: (TMUS) (MSFT) (GLW) High; (TDW) (WIT) (BMY) Low
Oct 24, 2016 08:27AM BMO Capital Remains Cautious on Bristol-Myers Squibb (BMY) Despite Decline; PT Lowered to $56
Oct 10, 2016 09:17AM Pre-Open Stock Movers 10/10: (IPCI) (TSRO) (MYL) Higher; (TWTR) (BMY) (DOV) Lower (more...)
Sep 1, 2016 08:51AM Bristol-Myers Squibb (BMY): Roche Study Highlights Increasing Competition - BMO
Aug 5, 2016 10:00AM Bristol-Myers (BMY) Opdivo Trial Miss a 'Seismic Event', BMO Capital Says (MRK)
Jan 25, 2016 06:22AM BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
Jan 12, 2016 01:46PM Bristol-Myers (BMY) JP Morgan Update 'Incrementally Positive', Negative for Merck (MRK) - BMO Capital
Sep 29, 2015 10:34AM Notable Analyst Rating Changes 9/29: (MU) (BMY) (RJET) Upgraded; (SCCO) (VSTM) (SQNM) Downgraded
Sep 16, 2015 02:07PM BMO Positive on Bristol-Myers Squibb's (BMY) Receipt of FDA Breakthrough Therapy Designation for Opdivo
Jul 20, 2015 12:10PM Streetinsider.com's Hot Lunchtime Reads 7/20: (AAPL) (BUD) (TSLA) (BMY)
View Older Stories